ATRX and cancer: In 288 OS tumors surveyed by the American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange (GENIE) Consortium, ATRX was one of the most frequently mutated genes, second only to TP53 (18–20) (Figure 1B).